Home

Insights

Dividend

Tatva Chintan Pharma Chem Ltd dividend

Tatva Chintan Pharma Chem Ltd dividend

download
stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

2.7 K

stocks traded

Last Updated time: 13 Jul 12:11 PM

Image

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

DPS

2

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Tatva Chintan Pharma Chem Ltd is ₹ 2 as of 2023 .a1#The Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2019 to 10.96 % on March 2023 . This represents a CAGR of -17.56% over 3 years. a1#The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 1152 as of 12 Jul 15:30 .a1#The Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2019 to ₹ 3694 crore on March 2023 . This represents a CAGR of -15.01% over 2 years. a1#The Revenue of Tatva Chintan Pharma Chem Ltd changed from ₹ 90.28 crore to ₹ 102.79 crore over 8 quarters. This represents a CAGR of 6.70% a1#The EBITDA of Tatva Chintan Pharma Chem Ltd changed from ₹ 17.09 crore to ₹ 20.14 crore over 8 quarters. This represents a CAGR of 8.56% a1#The Net Pr of Tatva Chintan Pharma Chem Ltd changed from ₹ 9.8 crore to ₹ 9.61 crore over 8 quarters. This represents a CAGR of -0.97% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Tatva Chintan Pharma Chem Ltd

Market Cap

2,695 Cr

EPS

13.0

P/E Ratio (TTM) *

88.8

P/B Ratio (TTM) *

3.7

DTE *

0.0

ROE *

4.1

ROCE *

6.7

Dividend Yield *

0.12

DPS *

2

Dividend Payout *

10.96

Ann.Dividend % *

20

* All values are consolidated

Last Updated time: 13 Jul 12:11 PM

* All values are consolidated

Last Updated time: 13 Jul 12:11 PM

×

Historical Dividend Payout of Tatva Chintan Pharma Chem Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Tatva Chintan Pharma Chem Ltd

Period
Mar '190
Mar '200
Mar '2120
Mar '225
Mar '2311

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

PRICE

1152.1

-1.00 (-0.09%)

stock direction

Last updated : 12 Jul 15:30

SWOT Analysis Of Tatva Chintan Pharma Chem Ltd

Strength

3

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Tatva Chintan Pharma Chem Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Tatva Chintan Pharma Chem Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '225115
Mar '233695

* All values are a in crore

×

Historical Revenue of Tatva Chintan Pharma Chem Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Tatva Chintan Pharma Chem Ltd

Period
Jun '2290
Sep '2292
Dec '22122
Mar '23125
Jun '23115
Sep '2397
Dec '2385
Mar '24103

* All values are a in crore

×

Historical EBITDA of Tatva Chintan Pharma Chem Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Tatva Chintan Pharma Chem Ltd

Period
Jun '2217
Sep '2213
Dec '2219
Mar '2314
Jun '2322
Sep '2321
Dec '2312
Mar '2420

* All values are a in crore

×

Historical Net Profit of Tatva Chintan Pharma Chem Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Tatva Chintan Pharma Chem Ltd

Period
Jun '2210
Sep '227
Dec '2212
Mar '2317
Jun '2310
Sep '238
Dec '233
Mar '2410

* All values are a in crore

About Tatva Chintan Pharma Chem Ltd

About Tatva Chintan Pharma Chem Ltd

    The Company was formerly incorporated as Tatva Chintan Pharma Chem Private Limited in India on 12 June 1996 under the Companies Act 2013. The status of the Company got converted from Private Limited into a Public Limited Company effective from 27 January 2021 and consequently, the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'. The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is primarily engaged in manufacturing and selling of specialty chemicals, Pharma & Agro intermediates and Quaternary Ammonium Compounds (Quats). The Company is a globally recognized specialty chemical player with several market leading products in its portfolio. Considering the wide application of products, the Company supply products to leading global companies across diverse industries, like automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care and flavor and fragrances with over 1300 customers. Apart from customers in India, the Company export products across the globe including USA, China, Germany, Japan, South Africa and UK. The Company operate through two world class manufacturing facilities located at Dahej and Ankleshwar in Gujarat both of which are strategically located very close to the Hazira Port. These units provide the Company cost and logistics advantage and enabling seamless export and import operations. The Company's manufacturing facilities obtained ISO 9001:2015 and 14001:2015 certification for robust quality management systems. Employing modern equipment like reactors, assembly lines, ANFDs, centrifuges and RCVDs, enabled the Company to undertake multiple chemistry process. The Company successfully established an integrated model comprising world class manufacturing infrastructure, complex & chemical processes, warehousing facilities and technically sound R&D capabilities, which enables to achieve high operational efficiency and quality, to innovate & customize and to ensure sustainable operations with wide offerings. The Company has sophisticated quality control lab equipped with modern analytical equipment, enabling it to detect impurities upto PPM levels and achieve ultra-pure'grade certification. The Company Promoters identified an opportunity in manufacturing Phase Transfer Catalyst (PTC), which is a niche segment within the specialty chemicals space. With PTC as the base, the Company have marked presence in the entire value chain including PTC, Structure Directing Agents (SDA), Electrolyte Salts (ES) and Pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). The Company have a dedicated Department of Scientific and Industrial Research (DSIR) approved R&D centre at its Vadodara facility where qualified and experienced in-house R&D team focus on development of new products and improvement in current manufacturing processes. The Company is having modern systems and analytical development laboratory with state-of-the-art instrumentation. In 2004, the Company received licence from the FDA, Gujarat at its Ankleshwar manufacturing plant. In 2007, the Company commenced Ankleshwar manufacturing facility and increased the expansion of manufacturing capacity. In 2011, the Company started commercial manufacturing of Structure Directing Agents (SDA). In 2015, the Company was accredited Appreciation Certificate for the Ankleshwar Plant from the Office of the Chief Commission of Central Excise, Customs & Service Tax, Vadodara Zone for its contribution to revenue and voluntary compliance with tax laws. The Company achieved revenue of nearly Rs 1 bn. The Company established a warehousing plant in The Netherlands. Tatva Chintan USA Inc. was incorporated as a wholly owned Subsidiary of TCPCL. In 2016, the Company was accorded the status of a two-star export house for the Ankleshwar plant from the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry (MoCI), Government of India (GoI). In 2017, manufacturing plant was established in Dahej, Gujarat. In 2018, the R&D facility was set up in Vadodara. Tatva Chintan Europe BV, was incorporated as wholly owned Subsidiary of the Company in year 2019. In FY 2019-20, the Company's Ankleshwar unit was converted to a zero liquid effluent discharge facility. The products proved efficiency to ensure lower by-products and waste generation in chemical processes. Additionally, the Company participated in the Together for Sustainability' initiatives whereby sustainability sourcing practices of chemical suppliers, like ecological and social aspects were assessed. Under this initiative, the Company involved Ecovadis to audit sustainability practices and performance, the results of which were above the industry average. This created a robust initiative and focused on retaining key customers who consider sustainability an important parameter to do business. In 2020, the Company achieved another Rs 2 billion revenue. In 2021, the manufacturing capacity at Dahej facility in Gujarat increased giving rise to aggregate installed reactor manufacturing capacity of the Company from 160 KL and 10 Assembly Lines to 280 KL and 17 Assembly Lines respectively. During the year 2021, the Company had issued 12,052,500 Equity Shares as Bonus Shares to all the existing shareholders of the Company in the ratio of 1.5:1 vide Board Resolution dated 03 March 2021 which was passed pursuant to passing of Special Resolution by Shareholders in ExtraOrdinary General Meeting held on 27 January 2021 against existing 8,035,000 Equity Shares.

Tatva Chintan Pharma Chem Ltd News Hub

News

Tatva Chintan Pharma Q4 PAT drops 43% YoY to Rs 96 cr

Revenue from operations fell 21.08% YoY to Rs 98.26 crore in Q4 FY24. During the quarter, ...

Read more

04 May 202413:28

News

Board of Tatva Chintan Pharma Chem recommends final dividend

Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meet...

Read more

03 May 202416:15

News

Tatva Chintan Pharma Chem to convene board meeting

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

25 Apr 202410:26

News

Tatva Chintan Pharma hits 52-week low after reporting weak Q3 numbers

Revenue from operations fell 30.18% YoY to Rs 842.06 crore in Q3 FY24. During the quarter,...

Read more

23 Jan 202411:17

News

Tatva Chintan Pharma reports weak numbers in Q3; PAT drops 70% YoY

Revenue from operations fell 30.18% YoY to Rs 842.06 crore in Q3 FY24. During the quarter,...

Read more

22 Jan 202414:05

News

Tatva Chintan Pharma Chem to convene board meeting

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

12 Jan 202410:53

FAQs for dividends of Tatva Chintan Pharma Chem Ltd

What is the current market price of Tatva Chintan Pharma Chem Ltd Ltd as of July 13, 2024?

The current market price of Tatva Chintan Pharma Chem Ltd Ltd stands at 1152.1 per share.

What dividend did Tatva Chintan Pharma Chem Ltd declare in the last fiscal year?

In the last fiscal year, Tatva Chintan Pharma Chem Ltd declared a dividend totaling ₹2.0.

What is the most recent dividend declared by Tatva Chintan Pharma Chem Ltd?

Tatva Chintan Pharma Chem Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Tatva Chintan Pharma Chem Ltd declared dividends in the current fiscal year

Tatva Chintan Pharma Chem Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Tatva Chintan Pharma Chem Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Tatva Chintan Pharma Chem Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199